These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3127968)
1. Use of difluoromethylornithine (DFMO, eflornithine) for late-stage African trypanosomiasis. McCann PP; Bitonti AJ; Bacchi CJ; Clarkson AB Trans R Soc Trop Med Hyg; 1987; 81(4):701-2. PubMed ID: 3127968 [No Abstract] [Full Text] [Related]
2. Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO). Jennings FW Trop Med Parasitol; 1992 Jun; 43(2):106-9. PubMed ID: 1519020 [TBL] [Abstract][Full Text] [Related]
3. Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system. Jennings FW Trans R Soc Trop Med Hyg; 1992; 86(3):257-8. PubMed ID: 1412647 [TBL] [Abstract][Full Text] [Related]
4. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin. Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061 [TBL] [Abstract][Full Text] [Related]
5. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense]. Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO). Jennings FW Trop Med Parasitol; 1991 Jun; 42(2):135-8. PubMed ID: 1654590 [TBL] [Abstract][Full Text] [Related]
7. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice. Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826 [TBL] [Abstract][Full Text] [Related]
8. Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'Ivoire. Doua F; Boa FY; Schechter PJ; Miézan TW; Diai D; Sanon SR; De Raadt P; Haegele KD; Sjoerdsma A; Konian K Am J Trop Med Hyg; 1987 Nov; 37(3):525-33. PubMed ID: 3120607 [TBL] [Abstract][Full Text] [Related]
9. The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis. Jennings FW Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):595-607. PubMed ID: 2848638 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis. Clarkson AB; Bacchi CJ; Mellow GH; Nathan HC; McCann PP; Sjoerdsma A Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5729-33. PubMed ID: 6193522 [TBL] [Abstract][Full Text] [Related]
11. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis]. Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492 [TBL] [Abstract][Full Text] [Related]
12. Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms of Trypanosoma brucei brucei. Demey F Vet Res Commun; 1987; 11(3):271-4. PubMed ID: 2442883 [TBL] [Abstract][Full Text] [Related]
13. Further studies on difluoromethylornithine in African trypanosomes. McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860 [TBL] [Abstract][Full Text] [Related]
14. Late-stage African trypanosomiasis and eflornithine. di Bari C; Pastore G; Roscigno G; Schechter PJ; Sjoerdsma A Ann Intern Med; 1986 Nov; 105(5):803-4. PubMed ID: 3094420 [No Abstract] [Full Text] [Related]
15. Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients. Taelman H; Schechter PJ; Marcelis L; Sonnet J; Kazyumba G; Dasnoy J; Haegele KD; Sjoerdsma A; Wery M Am J Med; 1987 Mar; 82(3 Spec No):607-14. PubMed ID: 3103442 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients]. Taelman H; Marcelis L; Sonnet J; Kazyumba G; Van den Enden E; Wery M; Schechter PJ Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):578-88. PubMed ID: 3143491 [TBL] [Abstract][Full Text] [Related]
17. Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Scalabrino G Am J Med; 1987 Nov; 83(5):1012-3. PubMed ID: 3118710 [No Abstract] [Full Text] [Related]
18. [Uveo-meningitis revealing a West African trypanosomiasis in a 12-year-old girl]. Buissonnière RF; De Boissieu D; Tell G; Bursztyn J; Belliot P; Ponsot G Arch Fr Pediatr; 1989; 46(7):517-9. PubMed ID: 2512891 [TBL] [Abstract][Full Text] [Related]
19. [DFMO: an alternative therapeutic agent for human African trypanosomiasis]. Breton JC; Bouteille B; Sonan T Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490 [TBL] [Abstract][Full Text] [Related]
20. Studies on lipidomimetic derivatives of alpha-difluoromethylornithine (DFMO) to enhance the bioavailability in a Trypanosoma B. brucei murine trypanosomiasis model. Loiseau PM; Czok M; Chauffert O; Bourass J; Letourneux Y Parasite; 1998 Sep; 5(3):239-46. PubMed ID: 9772723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]